Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
437.4 INR | +0.84% | +1.86% | +1.69% |
09:49am | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
04-25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.69% | 2.8B | |
+31.37% | 588B | |
-2.65% | 364B | |
+20.20% | 326B | |
+5.48% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.13% | 167B | |
+0.64% | 161B |
- Stock Market
- Equities
- LAURUSLABS Stock
- News Laurus Labs Limited
- Jefferies Adjusts Laurus Labs’ Price Target to INR260 From INR250, Keeps at Underperform